RXi Pharmaceuticals Announces $8.7 Million Private Placement
Tuesday June 24, 1:05 pm ET
WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (“RXi”) (NASDAQ: RXII - News), today announced that it has entered into definitive agreements with institutional investors to issue and sell an aggregate of 1,073,299 shares of its common stock in a private placement at a price of $8.12 per share, resulting in aggregate gross proceeds of approximately $8.7 million. Jefferies & Company acted as the lead placement agent and Natixis Bleichroeder Inc., Broadpoint Securities Group, Inc. and Griffin Securities, Inc. acted as the co-placement agents for the private placement. The private placement is expected to close on or around Wednesday, June 25, 2008, subject to customary closing conditions. |
